Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03988829 · ClinicalTrials.gov registry record · NA

Strategic Training to Optimize Neurocognitive Functions in Older Adults

A NA study, sponsored by The University of Texas at Dallas.

Completed
Registry status
NA
Development phase
75
Enrollment target

NCT03988829: Completed NA study, sponsored by The University of Texas at Dallas.

NCT03988829 is a NA study that has completed, run by The University of Texas at Dallas. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03988829, a NA study, has completed, sponsored by The University of Texas at Dallas.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target

Study Summary

The goal of the present randomized control trial is to evaluate the efficacy of a novel cognitive training approach using simulated games, where older adults will learn to flexibly deploy attentional control during working memory, for prevention of Alzheimer's Disease (AD). Based on our extensive pilot work, we expect training-related enhancements in both neural and cognitive functions on a broad range of cognitive abilities due to the importance of attentional control and working memory in many types of cognition. These outcomes are widely applicable to the cognitive health and the quality of life of elderly Americans, and have further potential to offset degenerative processes common to normal aging.

Primary Outcome

Change in composite score of episodic memory from baseline to post-training (i.e., after 8 weeks of training). The composite score of episodic memory will include correct responses from 3 episodic memory tasks: 1. Picture Sequence Memory 2. Rey Auditory Verbal Learning Test (RAVLT) 3. Story Recall (MMSE) For all tasks, alternative forms will be used for baseline testing and for post-training. Details of the tasks are listed below: 1. Participants are asked to reproduce a sequence of pictures

Interventions

  • BEHAVIORAL Low-C
  • BEHAVIORAL High-C
  • BEHAVIORAL High-C+

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2018-09-30
Est. Completion 2021-08-31
Phase NA
The University of Texas at Dallas

50 total trials

What the finished NCT03988829 record still lists

NCT03988829 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 3 interventions - of which Low-C is the first listed.

NCT03988829 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03988829 about?

NCT03988829 is a clinical study titled "Strategic Training to Optimize Neurocognitive Functions in Older Adults". The goal of the present randomized control trial is to evaluate the efficacy of a novel cognitive training approach using simulated games, where older adults will learn to flexibly deploy attentional control during working memory, for prevention of Alzheimer's Disease (AD). Based on our extensive pi...

What is the current status of trial NCT03988829?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2018-09-30. Estimated completion is 2021-08-31.

What interventions are being tested in trial NCT03988829?

The interventions under investigation include: Low-C (BEHAVIORAL), High-C (BEHAVIORAL), High-C+ (BEHAVIORAL).

Who is sponsoring clinical trial NCT03988829?

This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03988829's enrollment target sits among peer trials

75 1069th of 2000 higher than 919 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03988829, the US trial registry maintained by the National Library of Medicine. NCT03988829 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.